KUALA LUMPUR: Pharmaniaga Bhd
is looking to expand its presence in Southeast Asia and Africa by supplying finished Sinovac COVID-19 vaccine manufactured by its own high-technology plant.
Group managing director Datuk Zulkarnain Md Eusope said the Southeast Asian region, with a population of over 700 million, and the African continent, with its 1.3 billion population, offered tremendous potential for growth and would be the company’s focus areas to supply the vaccine.
